Discover Nabota 100 units, a game-changing type A botulinum toxin developed by Daewoong Pharmaceutical Co., Ltd. and officially approved by the U.S. Food and Drug Administration. Nabota, the first Korean botulinum toxin to break into the U.S. market, positions itself as an affordable alternative to Botox, offering the same potency without necessitating changes in handling practices for this potentially hazardous material.

Nabota is a botulinum toxin type A that is effective in combating wrinkles caused by uncontrolled muscle tone and facial expressions. Developed by Daewoong Pharmaceutical Co., Ltd., a South Korean company with over 30 years of experience in biotechnology, Nabota is a proven and safe product. It works rapidly, has high standards of cleanliness, produces long-lasting effects, and doesn’t cause a “frozen” appearance. Nabota is also highly secure, providing added peace of mind for both practitioners and patients.

Application Areas:

• Smoothing wrinkles in the region of the eyebrows, nasolabial folds wrinkles in the area of the eyes and the mouth, periorbital and zones
• Blepharospasm elimination
• Hyperhidrosis elimination
• Botox lifting

Main Ingredients: 

• Clostridium Botulinum Toxin A type (strain: Clostridium Botulinum CBFC26)

Packing Unit:

• 1 vial 100 units/box